TrialRheumatology (Oxford, England)2018

Triamcinolone acetonide extended-release in patients with osteoarthritis and type 2 diabetes: a randomized, phase 2 study.

Steven J Russell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.